MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30119% above fair value
$4.07+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
MannKind net income
Net income is the profit left for shareholders after every expense, interest and tax.
MannKind's net income for the twelve months ending Jun 30, 2026 was -$43.61M, down 233.0% year over year. For fiscal 2025 it was $5.86M, down 78.7% from the year before. The highest annual figure on record is $125.66M in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.86M | -78.7% |
| FY2024 | Dec 31, 2024 | $27.59M | – |
| FY2023 | Dec 31, 2023 | -$11.94M | – |
| FY2022 | Dec 31, 2022 | -$87.40M | – |
| FY2021 | Dec 31, 2021 | -$80.93M | – |
| FY2020 | Dec 31, 2020 | -$57.24M | – |
| FY2019 | Dec 31, 2019 | -$51.90M | – |
| FY2018 | Dec 31, 2018 | -$86.98M | – |
| FY2017 | Dec 31, 2017 | -$117.33M | -193.4% |
| FY2016 | Dec 31, 2016 | $125.66M | – |
| FY2015 | Dec 31, 2015 | -$368.45M | – |
| FY2014 | Dec 31, 2014 | -$198.38M | – |
| FY2013 | Dec 31, 2013 | -$191.49M | – |
| FY2012 | Dec 31, 2012 | -$169.37M | – |
| FY2011 | Dec 31, 2011 | -$160.80M | – |
| FY2010 | Dec 31, 2010 | -$170.56M | – |
| FY2009 | Dec 31, 2009 | -$220.10M | – |
| FY2008 | Dec 31, 2008 | -$303.04M | – |
| FY2007 | Dec 31, 2007 | -$293.19M | – |
| FY2006 | Dec 31, 2006 | -$230.55M | – |
| FY2005 | Dec 31, 2005 | -$114.34M | – |
| FY2004 | Dec 31, 2004 | -$75.99M | – |
| FY2003 | Dec 31, 2003 | -$65.88M | – |
| FY2002 | Dec 31, 2002 | -$206.27M | – |
| FY2001 | Dec 31, 2001 | -$48.25M | – |
| FY2000 | Dec 31, 2000 | -$24.66M | – |
| FY1999 | Dec 31, 1999 | -$5.68M | – |
| FY1998 | Dec 31, 1998 | -$3.33M | – |
| FY1997 | Dec 31, 1997 | -$2.28M | – |
| FY1996 | Dec 31, 1996 | -$2.57M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$19.03M | -2949.1% |
| Q1 FY2026 | Mar 31, 2026 | -$16.62M | -226.3% |
| Q4 FY2025 | Dec 31, 2025 | -$15.95M | -314.9% |
| Q3 FY2025 | Sep 30, 2025 | $7.99M | -30.9% |
| Q2 FY2025 | Jun 30, 2025 | $668.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $13.16M | +23.8% |
| Q4 FY2024 | Dec 31, 2024 | $7.42M | +429.8% |
| Q3 FY2024 | Sep 30, 2024 | $11.55M | +571.1% |
| Q2 FY2024 | Jun 30, 2024 | -$2.01M | – |
| Q1 FY2024 | Mar 31, 2024 | $10.63M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.40M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.80M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$29.02M | – |
| Q1 FY2022 | Mar 31, 2022 | -$26.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$28.06M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.43M | – |
| Q2 FY2021 | Jun 30, 2021 | -$35.52M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.92M | – |
| Q4 FY2020 | Dec 31, 2020 | -$26.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.26M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.32M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.26M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.37M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.39M | – |
| Q1 FY2019 | Mar 31, 2019 | -$14.88M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.75M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$22.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$30.39M | – |
| Q4 FY2017 | Dec 31, 2017 | -$32.78M | -160.7% |
| Q3 FY2017 | Sep 30, 2017 | -$32.89M | -126.0% |
| Q2 FY2017 | Jun 30, 2017 | -$35.34M | – |
| Q1 FY2017 | Mar 31, 2017 | -$16.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.98M | – |
| Q3 FY2016 | Sep 30, 2016 | $126.52M | – |
See a number that looks wrong?